Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ono Pharmaceutical CoOPHLF 86 3-1 Month Momentum % is 0.41% as of Aug. 26, 2026. GuruFocus rates OPHLF with a GF Score™ of 86/100 and a GF Value™ of $13.94 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 65.69% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-26), Ono Pharmaceutical Co's 3-1 Month Momentum % is 0.41%.
The industry rank for Ono Pharmaceutical Co's 3-1 Month Momentum % or its related term are showing as below:
OPHLF's 3-1 Month Momentum % is ranked better than 65.69% of 1020
companies
in the Drug Manufacturers industry
Industry Median: -5.825
vs OPHLF: 0.41
Ono Pharmaceutical Co (OTCPK:OPHLF) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Ono Pharmaceutical Co 3-1 Month Momentum % Related Terms
OPHLF vs LLY, JNJ, ABBV: 3-1 Month Momentum % Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co 3-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's 3-1 Month Momentum % falls into.
Ono Pharmaceutical Co (OTCPK:OPHLF) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (OPHLF) has a 3-1 Month Momentum % of 0.41% as of Aug. 26, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Ono Pharmaceutical Co and its competitors. According to the industry distribution chart, Ono Pharmaceutical Co ranks #350 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 34.3%.
Is Ono Pharmaceutical Co's 3-1 Month Momentum % too high?
Ono Pharmaceutical Co's current 3-1 Month Momentum % is 0.41%. Based on the distribution chart, Ono Pharmaceutical Co ranks #350 out of 1020 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ono Pharmaceutical Co has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's 3-1 Month Momentum % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #350 out of 1020 companies for 3-1 Month Momentum %. This puts Ono Pharmaceutical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
A good 3-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Ono Pharmaceutical Co and its competitors. Ono Pharmaceutical Co's current 3-1 Month Momentum % is 0.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (OPHLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $13.94, compared to a current price of $15.86 — trading 13.8% above its estimated fair value. The current 3-1 Month Momentum % is 0.41%. Ono Pharmaceutical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Ono Pharmaceutical Co (OPHLF), the current 3-1 Month Momentum % is 0.41% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (OPHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of $15.86 is trading 13.8% above its estimated GF Value™ of $13.94.
GuruFocus considers Ono Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for OPHLF:
3-1 Month Momentum %: 0.41%
GF Value™: $13.94 vs. price of $15.86 (13.8% above fair value)
No single metric tells the full story. See the OPHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
86GF Score
Get the complete analysis for OPHLF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPHLF has been successfully added to your 
